#PartneringAgainstCovid19
To support the fight against COVID-19 and accelerate global collaboration, Lyonbiopole, Evaluate Ltd. and Inova are organizing a free Virtual Partnering Event for organizations with solutions for COVID-19 testing, treatment and prevention.
Why a free Virtual Partnering Conference?
It falls to pharmaceutical companies, biotechs, academia, research scientists, public health agencies, VCs, CRO/CMOs and their suppliers to coordinate the industry’s response to the COVID-19 pandemic.
In normal times, thousands of organizations would gather in a large conference center to meet and exchange. Clearly and unfortunately, that is not an option today.
Instead, leveraging our biopharma industry expertise, our leading digital networking platform and years of experience organizing partnering events, we at Inova, together with Lyonbiopole and Evaluate Ltd are mounting this free Virtual Partnering Event to foster connections and accelerate global collaboration. It’s is our way of contributing to the battle against COVID-19.
What is a virtual Partnering Event?
It’s a conference of virtual face-to-face meetings. All meetings are online instead of at a physical location.
Who will attend?
Participation is open to any organization that provides product, knowledge, or technologies that can help in the effort to develop testing, treatment, or prevention solutions to tackle the COVID-19 pandemic.
The Event will bring these stakeholders together to pursue:
- Potential R&D collaborations
- Tools for research projects
- Drug repurposing
- Partners for clinical trials
- Funding and licensing
- Animal and in-silico models
- New suppliers for supply chain reinforcement
- Early stage discovery collaboration
- Production capabilities and scale-up know-how
- Biological markers and
- diagnostic tests for clinical trials
- Adjuvants, carrier systems, and formulation technologies
About the Virtual Partnering Platform
This event will leverage Inova’s matchmaking platform, One-on-One Partnering, that has been at the heart of major international biopharmaceutical conventions since 2015. It’s the leading partnering system that facilitates thousands of face-to-face meetings at dozens of biopharma conferences worldwide including the BIO International Convention and BIO Asia. For instance, in the weeks before the BIO International Convention, 4,000 biopharma companies connect online, list their technologies and capabilities, and request meetings with potential partners. By the time the Convention opens thousands of relevant meetings are scheduled – almost 50,000 at BIO Convention 2019 alone.
